Summary

PRA worked with an emerging biotech firm to implement a first-in-human clinical trial using a live biotherapeutic product for a rare disease indication.​

Register to download

Multi-stakeholder Collaboration Achieves Rapid Study Start-up for an Advanced Therapeutic

You may also be interested in: